Learning from prepandemic data to forecast viral escape
Citations Over TimeTop 1% of 2023 papers
Abstract
Effective pandemic preparedness relies on anticipating viral mutations that are able to evade host immune responses to facilitate vaccine and therapeutic design. However, current strategies for viral evolution prediction are not available early in a pandemic-experimental approaches require host polyclonal antibodies to test against1-16, and existing computational methods draw heavily from current strain prevalence to make reliable predictions of variants of concern17-19. To address this, we developed EVEscape, a generalizable modular framework that combines fitness predictions from a deep learning model of historical sequences with biophysical and structural information. EVEscape quantifies the viral escape potential of mutations at scale and has the advantage of being applicable before surveillance sequencing, experimental scans or three-dimensional structures of antibody complexes are available. We demonstrate that EVEscape, trained on sequences available before 2020, is as accurate as high-throughput experimental scans at anticipating pandemic variation for SARS-CoV-2 and is generalizable to other viruses including influenza, HIV and understudied viruses with pandemic potential such as Lassa and Nipah. We provide continually revised escape scores for all current strains of SARS-CoV-2 and predict probable further mutations to forecast emerging strains as a tool for continuing vaccine development ( evescape.org ).
Related Papers
- → Viral escape mechanisms – escapology taught by viruses(2001)117 cited
- → Implications of localized charge for human influenza A H1N1 hemagglutinin evolution: Insights from deep mutational scans(2020)8 cited
- → Identifying vaccine escape sites via statistical comparisons of short-term molecular dynamics(2022)7 cited
- → Possible contribution of rare alleles of human ACE2 in the emergence of SARS-CoV-2 variants escaping the immune response(2023)3 cited
- → Mutational Immune Escape in HIV-1 Infection(2015)1 cited